Clinuvel Pharmaceuticals Ltd.


CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV) is a global biopharmaceutical that is into development of SCENESSE (its proprietary first-in-class drug, as a photoprotective) to manage a range of UV and light related skin disorders and other products for treating genetic disorders.

Contact Information

company address Level 11, 535 Bourke Street, MELBOURNE, VIC, AUSTRALIA, 3000

company phone61 3 9660 4900

company website

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK